Three Phases of Growth
Prove it. Scale it. Institutionalise it. In that order.
- Rooms A, B, C and E active (Room F opens Y2)
- 55→140 cases resolved
- First audited Impact Report
- First MOU with palliative service
- Revenue: $470K → $1.11M
- Headcount: 2→4 FTE
- Board: 5 directors × $3K × 4 meetings = $60K p.a.
- Rooms D and F at full activity
- 280→820 cases per year
- First government commissioning
- Peer-reviewed publication
- Revenue: $2.43M → $10M
- Headcount: 8→22 FTE
- Board: 7 directors × $3K × 4 meetings = $84K p.a.
- Room G international opens
- 1,400→5,000+ cases per year
- National policy inclusion
- Endowment reaches $10M
- Revenue: $10M → $100M
- Headcount: 38→120+ FTE
- Board: 9 directors × $3K × 4 meetings = $108K p.a.
Total Portfolio Revenue: 10-Year Trajectory
Full 10-Year Revenue Model: By Room
Year-on-year portfolio breakdown across all seven funding rooms.
| Room | Y1 | Y2 | Y3 | Y4 | Y5 | Y6 | Y7 | Y8 | Y9 | Y10 |
|---|---|---|---|---|---|---|---|---|---|---|
| A: Philanthropic Foundations | $200K | $500K | $900K | $1.6M | $2.5M | $4M | $6M | $8M | $10M | $13M |
| B: Corporate Partners | $80K | $200K | $450K | $950K | $1.5M | $3M | $5M | $7M | $9M | $12M |
| C: General Public (donors) | $100K | $250K | $550K | $1.0M | $1.5M | $2.5M | $4M | $6M | $8M | $10M |
| D: Government Grants | — | — | $250K | $950K | $2M | $5M | $8M | $15M | $22M | $35M |
| E: Bequests & Major Gifts | $30K | $80K | $180K | $500K | $1M | $2M | $3M | $5M | $7M | $10M |
| F: Health Sector (MOU fees) | — | $50K | $100K | $450K | $1M | $3M | $5M | $8M | $12M | $18M |
| G: International Replication | — | — | — | — | $500K | $2M | $4M | $7M | $10M | $12M |
| CMS in-kind (related-party) | $60K | $30K | — | — | — | — | — | — | — | — |
| TOTAL PORTFOLIO | $470K | $1.11M | $2.43M | $5.45M | $10M | $21.5M | $35M | $56M | $78M | $100M |
| YoY Growth | — | +136% | +119% | +124% | +83% | +115% | +63% | +60% | +39% | +28% |
Note: Room D (Government) is the dominant scaling lever from Y5 onwards. Its activation at Y3 depends entirely on the quality of the evidence base built in Y1–Y2. This is why investment in measurement from day one is not optional; it is the prerequisite for the entire growth model. CMS in-kind contribution (Y1 $60K, Y2 $30K) is shown separately because it is a related-party in-kind contribution, not an external fundraising room.
Business Operating Model: Year-on-Year Scaling
Headcount, cases, debt resolved, and cost structure as the BOM grows from 2 to 120+ people.
Headcount by Year
Annual Cases Resolved
Business Operating Model: Full 10-Year Table
| Metric | Y1 | Y2 | Y3 | Y4 | Y5 | Y6 | Y7 | Y8 | Y9 | Y10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total FTE | 2 | 4 | 8 | 14 | 22 | 38 | 55 | 75 | 95 | 120 |
| Licensed Mediators | 1 | 2 | 4 | 7 | 11 | 18 | 26 | 36 | 46 | 58 |
| Case Coordinators | 1 | 2 | 3 | 5 | 7 | 12 | 18 | 24 | 32 | 40 |
| Annual Cases Resolved | 55 | 140 | 280 | 550 | 820 | 1,400 | 2,100 | 2,900 | 3,900 | 5,000 |
| CEO Salary (Laurence Hugo) | $165K | $170K | $175K | $180K | $186K | $192K | $197K | $203K | $209K | $216K |
| Board Sitting Fees ($3K × 4 × N) | $60K | $60K | $84K | $84K | $84K | $108K | $108K | $108K | $108K | $108K |
| Debt Resolved ($M) | $3.2M | $8.2M | $16.4M | $32.3M | $48.1M | $82.2M | $123M | $170M | $229M | $294M |
| Avg Debt per Case | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K | $58.7K |
| Cost per Case | $1,840 | $1,720 | $1,650 | $1,580 | $1,520 | $1,430 | $1,380 | $1,350 | $1,320 | $1,300 |
| Total Annual OPEX (on-book) | $443K | $593K | $668K | $4.74M | $8.7M | $18.7M | $30.5M | $48.7M | $67.9M | $87M |
| Of which: Direct Service | $340K | $485K | $555K | $4.12M | $7.6M | $16.3M | $26.5M | $42.4M | $59.1M | $75.7M |
| Of which: Overhead (incl. CEO & Board) | $103K | $108K | $113K | $616K | $1.1M | $2.4M | $4.0M | $6.3M | $8.8M | $11.3M |
| Annual Surplus (Revenue – OPEX) | +$27K | +$517K | +$1.76M | +$711K | +$1.3M | +$2.8M | +$4.5M | +$7.3M | +$10.1M | +$13M |
| Direct Service Ratio | 77% | 82% | 83% | 87% | 87% | 87% | 87% | 87% | 87% | 87% |
| Cumulative Cases (total) | 55 | 195 | 475 | 1,025 | 1,845 | 3,245 | 5,345 | 8,245 | 12,145 | 17,145 |
| Cumulative Debt Resolved | $3.2M | $11.4M | $27.9M | $60.2M | $108M | $190M | $313M | $484M | $713M | $1.007B |
The $1 billion milestone: Based on the model above, Life Without Debt will resolve its cumulative one-billionth dollar of debt in Year 10. Across 17,145 families. From a Year 1 fundraising base of $470K (against $443K of OPEX, including a $165K CEO salary and $60K of board sitting fees). The ROI of founding investment is not linear; it is compounding, because every case builds evidence, and every unit of evidence unlocks the next room of funding.
Annual Debt Resolved: 10-Year Trajectory
Cost Structure & OPEX Architecture
How 87 cents per dollar flows to direct service as the organisation scales from $470K (Y1) to $100M (Y10). In the foundation years (Y1–Y3) the ratio dips to 77–83% as the CEO salary ($165K) and board sitting fees ($60K) are front-loaded onto a small OPEX base, then climbs back to the canonical 87% from Y4 onwards.
Year 1 OPEX Breakdown
Year 5 OPEX Breakdown
The Structural Integrity of the 87-Cent Promise
The 87% direct service ratio is not aspirational; it is structurally enforced by the relationship between Life Without Debt (the charity) and Credit Mediation Services Pty Ltd (the commercial entity). CMS absorbs all infrastructure overhead: office lease, IT systems, HR, compliance, finance, and management, and does not charge these costs to LWD.
This means that as LWD scales, the overhead it carries on its books does not grow. The 87c promise is not maintained by expense reduction discipline alone; it is maintained by architectural separation of charitable and commercial overhead.
- Executive remuneration policy: The CEO salary is Board-approved within a published range of $150,000–$180,000 base (set at the $165K midpoint, indexed at 3% p.a., reviewed against ACOSS & Pro Bono Australia NFP CEO surveys every two years). All other LWD-employed roles are capped at SCHADS Award Level 6 ($92K base). Senior technical roles (Technical Negotiator, future Clinical Director) are contracted via CMS at commercial rates and shown transparently in Professional Services.
- Board sitting fees: $3,000 per director per meeting × 4 meetings p.a. Disclosed in ACNC AIS. Fee is paid only for attended meetings. Total annual fee envelope: $60K (5-seat board Y1–Y2), $84K (7-seat Y3–Y5), $108K (9-seat Y6–Y10).
- Zero vanity policy: No conferences, awards nights, branded merchandise, or promotional spend charged to the charity budget.
- Annual audit: Direct service ratio independently audited and reported in the Annual Impact Report. The Y1–Y3 ratio (77–83%) reflects the front-loaded cost of professional leadership; from Y4 onwards the ratio reaches and holds at 87%+. If it ever falls below 85% after Y3 the Board must report the cause and remediation plan.
Room Activation Sequence & Critical Path
The order of room activation is not arbitrary; it is a dependency chain.
Revenue Contribution by Room: Y1 to Y10
The Critical Path to $10M
Every room depends on evidence produced by earlier rooms. Remove any link and the chain breaks:
| Room | Opens | Prerequisite | Blocker if Missed |
|---|---|---|---|
| A: Philanthropic Foundations | Y1 | ACNC registration, initial case data | No evidence base for other rooms |
| B: Corporate Partners | Y1 | ESG framework alignment, first impact report | Limits to seed contributions only |
| C: General Public (donors) | Y1 | Public website, digital ad capability, Transparency Pledge | Donor acquisition stalls without credibility |
| E: Bequests & Major Gifts | Y1 | Legal bequest wording, CLG governance confirmed | Major gifts take 2–5 years to convert; must start cultivation now |
| F: Health Sector (MOU fees) | Y2 | First MOU signed, referral data, 12 months of case outcomes | No commissioning without demonstrated referral pathway |
| D: Government Grants | Y3 | 2-year audited evidence base, Room F MOUs, health cost analysis | Without 2yr data, government will not commission. This is the $35M room by Y10. |
| G: International Replication | Y5 | Peer-reviewed publication, government commissioning, replication framework complete | International funders require demonstrated institutional legitimacy |
The single highest-leverage action in Year 1: Open and rigorously measure every case. Not because the cases themselves generate the revenue (they don't, at $1,840 each), but because the data they generate is worth $35M by Year 10 in unlocked government funding. Measurement is not overhead. It is the asset.
Sensitivity Analysis: What Happens If We Miss?
Three scenarios: Base Case, Conservative Case, Optimistic Case.
Three Scenarios: Y5 Revenue Range
Key Risk Assumptions & Mitigations
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| Room D (Government) delayed to Y4 | Medium | High: $35M at Y10 | Parallel PHN submission from Y2; build Room F evidence concurrently |
| Room A foundation fatigue / grant cycle mismatch | Medium | Medium: affects Y2–Y3 trajectory | Apply to 12+ foundations; diversify across state/national/private |
| Founder dependency (Laurence & Lisa Hugo) | Low (mitigated) | Critical without mitigation | CLG governance, Board succession plan, documented SOP manual, professional CEO role definition |
| Creditor resistance / negotiation failure rate increases | Low | Medium: affects case ROI claim | Licensed AFCA accreditation; diversified creditor types; AFCA escalation pathway |
| Evidence quality insufficient for government commissioning | Low (if measured correctly) | Critical | Measurement system designed from Day 1 to government evidence standards; independent evaluator engaged Y2 |
| Donor attrition rate exceeds 20% p.a. (Room C) | Medium | Medium: affects $1.5M target | Stewardship programme, personalised impact letters, cancel-anytime policy reduces resentment attrition |
Perpetuity Architecture: Built to Outlive Its Founders
Four structural pillars that ensure LWD continues regardless of who is running it, who is funding it, or what the economy is doing.
Endowment Growth: Y1 to Y10
The Year 10 State: What $100M Looks Like
Not a charity. A national infrastructure. A global model.
What Changes in the World by Year 10
- Australian palliative care standard of care: Financial distress screening is mandatory at intake in all government-funded palliative services. LWD holds national commissioning contracts.
- Peer-reviewed evidence base: At least five published studies in high-impact medical social work, palliative medicine, and health economics journals.
- STD recognised in policy: Sexually Transmitted Debt is named in ASIC hardship guidelines and referenced in ATO's deceased estates practice statement.
- Global replication: LWD model operating in at least New Zealand, United Kingdom, and Canada, serving an estimated 1,500 additional international families per year.
- Endowment at perpetuity: $10M endowment generates $400K/year. Even if every other funding stream evaporates, 217 Australian families per year receive specialist debt mediation, forever.
- Fully self-sustaining: No dependency on founding individuals. Professional leadership team. Board with succession plan. System documented and replicable.
The founding investment: The entire $100M Year 10 machine starts with $470K in Year 1, of which $200K comes from Room A (philanthropic foundations). That $200K — underwritten by a professional CEO at $165K and a properly remunerated 5-seat board — funds the cases that build the evidence. The evidence unlocks government. Government institutionalises the service. Institutionalisation builds the endowment. The endowment funds it forever. This is what it means to design a system, not run a programme.